Results 81 to 90 of about 253,415 (210)

Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India

open access: yesIndian Journal of Public Health, 2019
National Rabies Control Programme, India, is in operation since 2012–2013 without much impact due to poor funding and no set policy for the rabies prevention and control. An effort was made to develop a draft policy paper which can help the Government of
Mysore Kalappa Sudarshan   +1 more
doaj   +1 more source

A Novel, Safe, Non-Adjuvanted Alphavirus RNA Particle Vaccine Expressing the Rabies Virus Glycoprotein Induces a Three-Year Duration of Immunity in Dogs and Cats After a Single Vaccine Dose

open access: yesVaccines
Background/Objectives: To this day, rabies remains a significant global threat. This threat remains even with the availability of vaccines for humans, wildlife, and domestic animals, which are used as part of a series of interventions to attempt to ...
Ken Stachura   +5 more
doaj   +1 more source

Rabies Control - towards sustainable prevention at the source : Compendium of the OIE Global Conference on rabies control, 7.-9. September 2011, Incheon-Seoul (Republic of Korea)

open access: yes, 2012
Global perspective of rabies -- Towards sustainable prevention of rabies at the source : a case report from India -- Rabies in China -- Rabies elimination in Europe : a success story -- Epidemiological factors and control of rabies in North Africa ...

core  

Integrating the landscape epidemiology and genetics of RNA viruses: rabies in domestic dogs as a model [PDF]

open access: yes, 2012
Landscape epidemiology and landscape genetics combine advances in molecular techniques, spatial analyses and epidemiological models to generate a more real-world understanding of infectious disease dynamics and provide powerful new tools for the study of
Biek, R.   +7 more
core   +1 more source

The unsung virtue of thermostable anti-rabies vaccine

open access: yesOpen Veterinary Journal
Vaccination is the most effective tool to protect against rabies. Currently, two different types of vaccines, i.e., tissue culture and cell culture vaccines, are available for prophylaxis against rabies in both animals and humans.
Krishna Prasad Acharya, Sarita Phuyal
doaj   +1 more source

Rabies /

open access: yes, 2002
Rabies offers a complete account of one of the oldest known diseases threatening public health today. Unlike most research-oriented descriptions of rabies, this book provides a narrative about the disease and its etiologic agent, encompassing the ...
Jackson, Alan C., Wunner, William H.
core  

Rabies

open access: yes, 2017
International audienceRabies is a zoonotic disease caused by viruses of the Lyssavirus genus (in the family Rhabdoviridae of the order Mononegavirales) that was first described in the 4th century BC 1.
Nadin-Davis, Susan   +30 more
core   +1 more source

RABIES IN UKRAINE: EPIDEMIOLOGICAL AND EPIZOOTIC SITUATION, MEANS FOR PREVENTIVE AND THERAPEUTIC IMMUNIZATION [PDF]

open access: yesAnnals of Mechnikov's Institute, 2013
Epidemiological and epizootic situations of rabies in Ukraine were analyzed. Active centers of animal rabies formed in many areas where 2016 persons were attacked by animals (mostly dogs suspected on rabies) during 2011 year.
Lavrik A.,, Novikova O.,, Panchenko L.
doaj  

The feasibility of canine rabies elimination in Africa: dispelling doubts with data [PDF]

open access: yes, 2010
<p><b>Background:</b> Canine rabies causes many thousands of human deaths every year in Africa, and continues to increase throughout much of the continent.</p> <p><b>Methodology/Principal Findings:</b> This ...
Katie Hampson   +29 more
core   +1 more source

Studies on candidate reference preparations of rabies vaccine

open access: yes, 1978
Two candidate reference rabies vaccines were tested in a collaborative study involving seven laboratories. Using four different testing procedures it was determined that both vaccine preparations were highly potent and demonstrated satisfactory stability
Diaz, A. M.   +8 more
core  

Home - About - Disclaimer - Privacy